2-Oxo-5-guanidinopentanoate

Details

Top
Internal ID 622758ed-380d-4a30-8769-0769ccbf2959
Taxonomy Organic acids and derivatives > Keto acids and derivatives > Short-chain keto acids and derivatives
IUPAC Name 5-(diaminomethylideneazaniumyl)-2-oxopentanoate
SMILES (Canonical) C(CC(=O)C(=O)[O-])C[NH+]=C(N)N
SMILES (Isomeric) C(CC(=O)C(=O)[O-])C[NH+]=C(N)N
InChI InChI=1S/C6H11N3O3/c7-6(8)9-3-1-2-4(10)5(11)12/h1-3H2,(H,11,12)(H4,7,8,9)
InChI Key ARBHXJXXVVHMET-UHFFFAOYSA-N
Popularity 74 references in papers

Physical and Chemical Properties

Top
Molecular Formula C6H11N3O3
Molecular Weight 173.17 g/mol
Exact Mass 173.08004122 g/mol
Topological Polar Surface Area (TPSA) 123.00 Ų
XlogP -0.90
Atomic LogP (AlogP) -4.56
H-Bond Acceptor 3
H-Bond Donor 3
Rotatable Bonds 5

Synonyms

Top
5-(diaminomethylideneazaniumyl)-2-oxopentanoate
2-Oxo-5-guanidinopentanoate
2-Oxo-5-guanidino-pentanoate
5-carbamimidamido-2-oxopentanoate
2-ketoarginine
alpha-ketoarginine
2-keto-5-guanidinovalerate
CHEBI:58489
5-guanidino-2-oxopentanoic acid zwitterion
5-{[amino(iminio)methyl]amino}-2-oxopentanoate

2D Structure

Top
2D Structure of 2-Oxo-5-guanidinopentanoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7319 73.19%
Caco-2 - 0.6839 68.39%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability + 0.7000 70.00%
Subcellular localzation Mitochondria 0.6738 67.38%
OATP2B1 inhibitior - 0.8528 85.28%
OATP1B1 inhibitior + 0.9370 93.70%
OATP1B3 inhibitior + 0.9461 94.61%
MATE1 inhibitior - 0.7000 70.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.9423 94.23%
P-glycoprotein inhibitior - 0.9831 98.31%
P-glycoprotein substrate - 0.9284 92.84%
CYP3A4 substrate - 0.6672 66.72%
CYP2C9 substrate - 0.8037 80.37%
CYP2D6 substrate - 0.8590 85.90%
CYP3A4 inhibition - 0.8929 89.29%
CYP2C9 inhibition - 0.9039 90.39%
CYP2C19 inhibition - 0.8734 87.34%
CYP2D6 inhibition - 0.9310 93.10%
CYP1A2 inhibition - 0.8345 83.45%
CYP2C8 inhibition - 0.9638 96.38%
CYP inhibitory promiscuity - 0.9820 98.20%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8211 82.11%
Carcinogenicity (trinary) Non-required 0.6604 66.04%
Eye corrosion - 0.9798 97.98%
Eye irritation + 0.6690 66.90%
Skin irritation - 0.7351 73.51%
Skin corrosion - 0.8220 82.20%
Ames mutagenesis - 0.6500 65.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7147 71.47%
Micronuclear - 0.5200 52.00%
Hepatotoxicity - 0.5375 53.75%
skin sensitisation - 0.8671 86.71%
Respiratory toxicity + 0.5333 53.33%
Reproductive toxicity - 0.6778 67.78%
Mitochondrial toxicity + 0.6875 68.75%
Nephrotoxicity - 0.7416 74.16%
Acute Oral Toxicity (c) III 0.4812 48.12%
Estrogen receptor binding - 0.8619 86.19%
Androgen receptor binding - 0.9145 91.45%
Thyroid receptor binding - 0.6967 69.67%
Glucocorticoid receptor binding - 0.7733 77.33%
Aromatase binding - 0.7956 79.56%
PPAR gamma - 0.6679 66.79%
Honey bee toxicity - 0.9496 94.96%
Biodegradation - 0.5000 50.00%
Crustacea aquatic toxicity - 0.8100 81.00%
Fish aquatic toxicity - 0.9695 96.95%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.58% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 88.07% 91.11%
CHEMBL3060 Q9Y345 Glycine transporter 2 86.65% 99.17%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 81.47% 96.95%

Cross-Links

Top
PubChem 25244978
NPASS NPC296427